As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At Sage Therapeutics, a filing with the SEC revealed that on Wednesday, Kevin P. Starr bought 17,842 shares of SAGE, at a cost of $56.05 each, for a total investment of $999,983. Sage Therapeutics is trading down about 0.3% on the day Thursday.
And at Customers Bancorp, there was insider buying on Monday, by Head of Corporate Development Samvir S. Sidhu who bought 6,000 shares for a cost of $39.53 each, for a trade totaling $237,184. Customers Bancorp is trading down about 4% on the day Thursday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.